Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Stephanie Huang

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
Annals of Translational Medicine|February 5, 2020
MicroRNA targeting energy metabolism in ovarian cancer: a potent contender for future therapeuticsSiddhika Pareek, Aritro Nath, R Stephanie Huang
Plos One|September 18, 2014
pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levelsPaul Geeleher, Nancy Cox, R Stephanie Huang
Bioinformatics (Oxford, England)|December 21, 2019
iMIRAGE: an R package to impute microRNA expression using protein-coding genesAritro Nath, Jeremy Chang, R Stephanie Huang
Chinese Journal of Cancer|May 13, 2015
Pharmacogenomics of EGFR-targeted therapies in non-small cell lung cancer: EGFR and beyondChristopher Delaney, Samuel Frank, R Stephanie Huang
Molecular Diagnosis & Therapy|July 13, 2017
Pharmacogenetics and Pharmacogenomics of Targeted Therapeutics in Chronic Myeloid LeukemiaAritro Nath, Jacqueline Wang, R Stephanie Huang
Pharmacogenomics and Personalized Medicine|September 28, 2011
Integrating Epigenomics into Pharmacogenomic StudiesWei Zhang, R Stephanie Huang, M Eileen Dolan
Genomics, Proteomics & Bioinformatics|December 3, 2014
Pharmacogenomics of cisplatin sensitivity in non-small cell lung cancerMaimon C Rose, Elina Kostyanovskaya, R Stephanie Huang
Genome Biology|March 4, 2014
Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell linesPaul Geeleher, Nancy J Cox, R Stephanie Huang
Genome Biology|September 23, 2016
Cancer biomarker discovery is improved by accounting for variability in general levels of drug sensitivity in pre-clinical modelsPaul Geeleher, Nancy J Cox, R Stephanie Huang
Trends in Cancer Research|September 28, 2011
Cell-based Models for Discovery of Pharmacogenomic Markers of Anticancer Agent ToxicityWei Zhang, R Stephanie Huang, M Eileen Dolan
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Annals of Translational Medicine|February 5, 2020
MicroRNA targeting energy metabolism in ovarian cancer: a potent contender for future therapeuticsSiddhika Pareek, Aritro Nath, R Stephanie Huang
Plos One|September 18, 2014
pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levelsPaul Geeleher, Nancy Cox, R Stephanie Huang
Bioinformatics (Oxford, England)|December 21, 2019
iMIRAGE: an R package to impute microRNA expression using protein-coding genesAritro Nath, Jeremy Chang, R Stephanie Huang
Chinese Journal of Cancer|May 13, 2015
Pharmacogenomics of EGFR-targeted therapies in non-small cell lung cancer: EGFR and beyondChristopher Delaney, Samuel Frank, R Stephanie Huang
Molecular Diagnosis & Therapy|July 13, 2017
Pharmacogenetics and Pharmacogenomics of Targeted Therapeutics in Chronic Myeloid LeukemiaAritro Nath, Jacqueline Wang, R Stephanie Huang
Pharmacogenomics and Personalized Medicine|September 28, 2011
Integrating Epigenomics into Pharmacogenomic StudiesWei Zhang, R Stephanie Huang, M Eileen Dolan
Genomics, Proteomics & Bioinformatics|December 3, 2014
Pharmacogenomics of cisplatin sensitivity in non-small cell lung cancerMaimon C Rose, Elina Kostyanovskaya, R Stephanie Huang
Genome Biology|March 4, 2014
Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell linesPaul Geeleher, Nancy J Cox, R Stephanie Huang
Genome Biology|September 23, 2016
Cancer biomarker discovery is improved by accounting for variability in general levels of drug sensitivity in pre-clinical modelsPaul Geeleher, Nancy J Cox, R Stephanie Huang
Trends in Cancer Research|September 28, 2011
Cell-based Models for Discovery of Pharmacogenomic Markers of Anticancer Agent ToxicityWei Zhang, R Stephanie Huang, M Eileen Dolan
Pageof 12